Zentalis Historical Income Statement

ZNTL Stock  USD 15.76  0.57  3.75%   
Historical analysis of Zentalis PharmaceuticalsL income statement accounts such as Net Interest Income of 469.1 K, Interest Income of 469.1 K, Depreciation And Amortization of 1.5 M or Interest Expense of 2.8 M can show how well Zentalis PharmaceuticalsLlc performed in making a profits. Evaluating Zentalis PharmaceuticalsL income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Zentalis PharmaceuticalsL's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Zentalis PharmaceuticalsL latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zentalis PharmaceuticalsL is a good buy for the upcoming year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

About Zentalis Income Statement Analysis

Zentalis PharmaceuticalsL Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Zentalis PharmaceuticalsL shareholders. The income statement also shows Zentalis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Zentalis PharmaceuticalsL Income Statement Chart

Zentalis PharmaceuticalsLlc Income Statement is one of the three primary financial statements used for reporting Zentalis's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zentalis PharmaceuticalsL revenue and expense. Zentalis PharmaceuticalsL Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Zentalis PharmaceuticalsL's Depreciation And Amortization is quite stable compared to the past year. Reconciled Depreciation is expected to rise to about 1.5 M this year, although the value of Tax Provision is projected to rise to (784.7 K).

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Zentalis PharmaceuticalsL. It is also known as Zentalis PharmaceuticalsL overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Zentalis PharmaceuticalsL's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Zentalis PharmaceuticalsL current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
At this time, Zentalis PharmaceuticalsL's Depreciation And Amortization is quite stable compared to the past year. Reconciled Depreciation is expected to rise to about 1.5 M this year, although the value of Tax Provision is projected to rise to (784.7 K).
 2010 2019 2023 2024 (projected)
Interest Income355K498K572.7K469.2K
Net Interest Income355K498K572.7K469.2K

Zentalis PharmaceuticalsL income statement Correlations

-0.54-0.540.14-0.70.88-0.720.790.830.79-0.730.76-0.72-0.90.820.270.830.990.78-0.840.870.77
-0.541.0-0.310.89-0.770.88-0.86-0.84-0.860.88-0.850.880.73-0.850.0-0.85-0.5-0.270.74-0.64-0.43
-0.541.0-0.310.89-0.770.88-0.86-0.84-0.860.88-0.850.880.73-0.850.0-0.85-0.5-0.270.74-0.64-0.43
0.14-0.31-0.31-0.320.14-0.450.40.230.4-0.490.51-0.46-0.110.24-0.890.220.210.55-0.16-0.1-0.15
-0.70.890.89-0.32-0.920.99-0.97-0.95-0.970.98-0.950.990.89-0.96-0.03-0.95-0.68-0.40.92-0.82-0.5
0.88-0.77-0.770.14-0.92-0.910.940.970.94-0.90.9-0.91-1.00.970.230.970.870.55-0.970.970.69
-0.720.880.88-0.450.99-0.91-0.98-0.94-0.981.0-0.981.00.88-0.950.1-0.94-0.72-0.510.91-0.78-0.48
0.79-0.86-0.860.4-0.970.94-0.980.981.0-0.980.99-0.98-0.930.99-0.010.980.770.53-0.890.830.63
0.83-0.84-0.840.23-0.950.97-0.940.980.98-0.940.95-0.94-0.961.00.181.00.790.47-0.910.90.73
0.79-0.86-0.860.4-0.970.94-0.981.00.98-0.980.99-0.98-0.930.99-0.010.980.770.53-0.890.830.63
-0.730.880.88-0.490.98-0.91.0-0.98-0.94-0.98-0.981.00.87-0.940.14-0.93-0.73-0.550.9-0.76-0.47
0.76-0.85-0.850.51-0.950.9-0.980.990.950.99-0.98-0.98-0.890.96-0.130.950.750.57-0.860.770.58
-0.720.880.88-0.460.99-0.911.0-0.98-0.94-0.981.0-0.980.88-0.950.1-0.94-0.72-0.510.91-0.78-0.48
-0.90.730.73-0.110.89-1.00.88-0.93-0.96-0.930.87-0.890.88-0.96-0.26-0.96-0.88-0.550.95-0.97-0.73
0.82-0.85-0.850.24-0.960.97-0.950.991.00.99-0.940.96-0.95-0.960.161.00.780.47-0.910.890.72
0.270.00.0-0.89-0.030.230.1-0.010.18-0.010.14-0.130.1-0.260.160.180.16-0.29-0.170.440.55
0.83-0.85-0.850.22-0.950.97-0.940.981.00.98-0.930.95-0.94-0.961.00.180.790.47-0.910.90.74
0.99-0.5-0.50.21-0.680.87-0.720.770.790.77-0.730.75-0.72-0.880.780.160.790.85-0.840.850.68
0.78-0.27-0.270.55-0.40.55-0.510.530.470.53-0.550.57-0.51-0.550.47-0.290.470.85-0.560.460.33
-0.840.740.74-0.160.92-0.970.91-0.89-0.91-0.890.9-0.860.910.95-0.91-0.17-0.91-0.84-0.56-0.93-0.52
0.87-0.64-0.64-0.1-0.820.97-0.780.830.90.83-0.760.77-0.78-0.970.890.440.90.850.46-0.930.73
0.77-0.43-0.43-0.15-0.50.69-0.480.630.730.63-0.470.58-0.48-0.730.720.550.740.680.33-0.520.73
Click cells to compare fundamentals

Zentalis PharmaceuticalsL Account Relationship Matchups

Zentalis PharmaceuticalsL income statement Accounts

201920202021202220232024 (projected)
Tax Provision15K444K(297K)(469K)(826K)(784.7K)
Depreciation And Amortization111K(683K)(52.0M)(6.0M)1.4M1.5M
Interest Expense1.2M2.2M110.0M2.6M3.0M2.8M
Selling General Administrative8.5M33.9M40.9M54.6M64.4M38.0M
Gross Profit(111K)(160K)(544K)(1.4M)(1.4M)(1.3M)
Other Operating Expenses46.8M118.8M216.5M227.3M253.9M162.7M
Operating Income(46.8M)(118.8M)(216.5M)(227.3M)(253.9M)(241.2M)
Net Income From Continuing Ops(46.4M)(118.5M)(164.3M)(220.8M)(286.4M)(272.0M)
Ebit(46.8M)(118.8M)(216.5M)(227.3M)(253.9M)(241.2M)
Research Development38.4M84.9M175.6M172.7M189.6M124.7M
Ebitda(46.7M)(119.5M)(268.5M)(233.3M)(252.6M)(239.9M)
Total Operating Expenses46.8M118.8M216.5M227.3M252.6M162.4M
Reconciled Depreciation111K160K544K1.4M1.4M1.5M
Income Before Tax(46.4M)(118.1M)(164.6M)(221.3M)(276.9M)(263.0M)
Total Other Income Expense Net482K683K52.0M6.0M(23.0M)(21.8M)
Net Income Applicable To Common Shares(45.7M)(117.8M)(158.7M)(236.8M)(213.1M)(202.5M)
Net Income(46.4M)(118.5M)(164.3M)(220.8M)(292.2M)(277.6M)
Income Tax Expense15K444K(297K)(469K)(601K)(571.0K)
Minority Interest6.8M24.8M(7.4M)(307K)105K99.8K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zentalis PharmaceuticalsL in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zentalis PharmaceuticalsL's short interest history, or implied volatility extrapolated from Zentalis PharmaceuticalsL options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Zentalis Stock analysis

When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.47)
Return On Assets
(0.29)
Return On Equity
(0.67)
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.